Neurotrophic molecules: Strategies for designing effective therapeutic molecules in neurodegeneration

Molecular and Cellular Neurosciences

Volumn 12, Issue 4-5, 1998, Pages 179-193

  Skaper, Stephen D ^a   Walsh, Frank S ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; CILIARY NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; TACROLIMUS;

ANIMAL CELL; BLOOD BRAIN BARRIER; DEGENERATIVE DISEASE; DRUG DISPOSITION; DRUG EFFECT; DRUG TARGETING; DRUG UPTAKE; ENZYME ACTIVATION; GROWTH REGULATION; IMMUNOREGULATION; NERVE DEGENERATION; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031760866     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1998.0714     Document Type: Review

References (127)

1. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
2. Apfel S. C., Kessler J. A. Neurotrophic factors in the treatment of peripheral neuropathy. Ciba Found. Symp. 196:1996;98-108.
3. Barbacid M. The trk family of neurotrophin receptors. J. Neurobiol. 25:1994;1386-1403.
4. Barde Y.-A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
5. Barde Y.-A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1:1982;549-553.
6. Barker P., Shooter E. Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells. Neuron. 13:1994;203-215.
7. Bar-Sagi D., Feramisco J. R. Microinjection of the ras oncogene protein into PC12 induces morphologic differentiation. Cell. 42:1985;841-848.
8. Bethel A., Kirsch J. R., Koehler R. C., Finklestein S. P., Traystman R. J. Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke. 28:1997;609-615.
9. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J. J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing glial cell line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA. 94:1997;8818-8823.
10. Bilsland J., Young L., Williams B., Swain C., Hefti F., Harper S. In vitro evaluation of GPI-1046, an immunophilin ligand with reported neurotrophic activity. Eur. J. Neurosci. 10:1998;390.
11. Bonni A., Frank D. A., Schindler C., Greenberg M. E. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science. 262:1993;1575-1579.
12. Borasio G. D., Horstmann S., Anneser J. M., Neff N. T., Glicksman M. A. CEP-1347/KT7515, a JNK pathway inhibitor, supports the in vitro survival of chick embryonic neurons. NeuroReport. 9:1998;1435-1439.
13. Borasio G. D., Markus A., Wittinghofer A., Barde Y.-A., Heumann R. Involvement of ras p21 in neurotrophin-induced response of sensory, but not sympathetic neurons. J. Cell Biol. 121:1993;665-672.
14. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18:1995;223-253.
15. Brambilla R., Klein R. Telling axons where to grow: A role for Eph receptor tyrosine kinases in guidance. Mol. Cell. Neurosci. 6:1995;487-495.
16. Braun W., Kallen J., Mikol V., Walkinshaw M. D., Wuthrich K. Three-dimensional structure and actions of immunosuppressants and their immunophilins. FASEB J. 9:1995;63-72.
17. Bruckner K., Klein R. Signaling by Eph receptors and their Ephrin ligands. Curr. Opin. Neurobiol. 8:1998;375-382.
18. Burgering B., Coffer P. Protein kinase B (Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
19. Butterworth N. J., Dragunow M. Medial septal cholinergic neurons express c-Jun but do not undergo DNA fragmentation after fornix-fimbria transections. Mol. Brain Res. 43:1996;1-12.
20. Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. T., Chao M. V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 383:1996;716-719.
21. Chao M. V. Neurotrophin receptors: A window into neuronal differentiation. Neuron. 9:1992;583-593.
22. S6K. Nature. 370:1994;71-75.
23. Condic M. L., Letourneau P. C. Ligand-induced changes in integrin expression regulate neuronal adhesion and neurite outgrowth. Nature. 389:1997;852-856.
24. Cowley S., Paterson H., Kemp P., Marshall C. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.
25. Creedon D. J., Johnson E. M. Jr., Lawrence J. C. Jr. Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J. Biol. Chem. 271:1996;20713-20718.
26. Crews C., Alessandrini A., Erikson E. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 258:1992;478-480.
27. Davies A. M., Lee K. F., Jaenisch R. p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron. 11:1993;565-575.
28. Denhardt D. T. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling. Biochem. J. 318:1996;729-747.
29. D'Mello S. R., Borodezt K., Soltoff S. P. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: Possible involvement of PI 3-kinase in IGF-1 signaling. J. Neurosci. 17:1997;1548-1560.
30. Dobrowsky R., Werner M., Castellino A., Chao M., Hannun Y. Activation of the sphingomyelin cycle through the low affinity neurotrophin receptor. Science. 265:1994;1596-1599.
31. Dodd J., Jessell T. M. Axon guidance and the patterning of neuronal projections in vertebrates. Science. 242:1988;692-699.
32. Doré S., Kar S., Quirion R. Rediscovering an old friend, IGF-1: Potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20:1997;326-331.
33. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., Greenberg M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
34. Ebendal T., Bengtsson H., Soderstrom S. Bone morphogenetic proteins and their receptors: Potential functions in the brain. J. Neurosci. Res. 51:1998;139-146.
35. Edelman G. M. A golden age for cell adhesion. Cell Adh. Commun. 1:1993;1-7.
36. Eilers A., Whitfield J., Babij C., Rubin L., Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18:1998;1713-1724.
37. Eriksdotter J. M., Nordberg A., Amberla K., Backman L., Ebendal T., Meyerson B., Olson L., Seiger A., Shigeta M., Theodorsson E., Viitanen M., Winblad B., Wahlund L. O. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9:1998;246-257.
38. Estus S., Zaks W. J., Freeman R. S., Gruda M., Bravo R., Johnson E. M. Jr. Altered gene expression in neurons during programmed cell death: Identification ofc-jun. J. Cell Biol. 127:1994;1717-1727.
39. Fanger G. R., Gerwins P., Widmann C., Jarpe M. B., Johnson G. L. MEKKs, GCKs, MLKs, PAKs, TAKs, and TPLs: Upstream regulators of the c-Jun amino-terminal kinases. Curr. Opin. Genet. Dev. 7:1997;67-74.
40. Friden P. M., Walus L. R., Watson P., Doctrow S. R., Kozarich J. W., Bäckman C., Bergman H., Hoffer B., Bloom F., Granholm A.-C. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science. 259:1993;373-377.
41. Frim D. M., Uhler T. A., Galpern W. R., Beal M. F., Breakefield X. O., Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA. 91:1994;5104-5108.
42. Glasky A. J., Melchior C. L., Pirzadeh B., Heydari N., Ritzmann R. F. Effect of AIT-082, a purine analog, on working memory in normal and aged mice. Pharmacol. Biochem. Behav. 47:1994;325-329.
43. Glasky A. J., Glasky M. S., Ritzmann R. F., Rathbone M. P. AIT-082, a novel purine derivative with neuroregenerative properties. Exp. Opin. Invest. Drugs. 6:1997;1413-1417.
44. Gold B. G. FK506 and the role of the immunophilins in nerve regeneration. Mol. Neurobiol. 15:1997;285-306.
45. Goodman C. S., Shatz C. J. Developmental mechanisms that generate precise patterns of neuronal connectivity. Cell/Neuron. 72:1993;77-98.
46. Götz R., Köster R., Winkler C., Raulf F., Lottspeich F., Schartl M., Thoenen H. Neurotrophin-6 is a new member of the nerve growth factor family. Nature. 372:1994;266-269.
47. Grill R., Murai K., Blesch A., Gage F. H., Tuszynski M. H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 17:1997;5560-5572.
48. Hallböök F., Ibáñez C. F., Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron. 6:1991;845-858.
49. Haase G., Kennel P., Pettmann B., Vigne E., Akli S., Revah F., Schmalbruch H., Kahn A. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat. Med. 3:1997;429-436.
50. Ham J., Babij C., Whitfield J., Pfarr C. M., Lallemand D., Yaniv M., Rubin L. L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron. 14:1995;927-939.
51. Hamburger V., Brunso-Bechthold J. K., Yip J. W. Neuronal death in the spinal ganglia of the chick embyro and its reduction by nerve growth factor. J. Neurosci. 1:1981;60-71.
52. Hefti F., Harper S., Bristow L., Boyce S., Swain C. Small molecule neurotrophic factor mimetics. Int. J. Neuropsychopharmacol. 1:1998;S10.
53. Hill C., Treisman R. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell. 80:1995;199-211.
54. Horstmann S., Kahle P. J., Borasio G. D. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J. Neurosci. Res. 52:1998;483-490.
55. Ibáñez C. F. Neurotrophic factors: From structure-function studies to designing effective therapeutics. TIBTECH. 13:1995;217-227.
56. Ip N. Y., Yancopoulos G. D. The neurotrophins and CNTF: Two families of collaborative neurotrophic factors. Annu. Rev. Neurosci. 19:1996;491-515.
57. Jaiswal R. K., Moodie S. A., Wolfman A., Landreth G. E. The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras. Mol. Cell. Biol. 14:1994;6944-6953.
58. Jing S., Tapley P., Barbacid M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron. 9:1992;1067-1079.
59. Jonsson E., Brene S., Zhang X. R., Nimgaonkar V. L., Tylec A., Schalling M., Sedvall G. Schizophrenia and neurotrophin-3 alleles. Acta Psychiatr. Scand. 1997;414-419.
60. Kaneko M., Saito Y., Saito H., Matsumoto T., Matsuda Y., Vaught J. L., Dionne C. A., Angeles T. S., Glicksman M. A., Neff N. T., Rotella D. P., Kauer J. C., Mallamo J. P., Hudkins R. L., Murakata C. Neurotrophic 3,9-bis[(alkylthio)methyl]- and -bis(alkoxymethyl)-K-252a derivatives. J. Med. Chem. 40:1997;1863-1869.
61. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385:1997;544-548.
62. Kawamata T., Dietrich W. D., Schallert T., Gotts J. E., Cocke R. R., Benowitz L. I., Finklestein S. P. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc. Natl. Acad. Sci. USA. 94:1997;8179-8184.
63. Kummer J. L., Rao P. K., Heidenreich K. A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;20490-20494.
64. Kyriakis J. M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
65. Lai K.-O., Fu W.-Y., Ip F. C. F., Ip N. Y. Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol. Cell. Neurosci. 11:1998;64-76.
66. Lange-Carter C. A., Johnson G. L. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science. 265:1994;1458-1461.
67. Lee K.-F., Li E., Huber L. J., Landis S. C., Sharpe A. H., Chao M. V., Jaenisch R. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell. 69:1992;737-749.
68. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y.-A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:1989;149-152.
69. LeSauteur L., Wei L., Gibbs B. F., Saragovi H. U. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J. Biol. Chem. 270:1995;6564-6569.
70. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
71. Lindsay R. M., Yancopoulos G. D. GDNF in a bind with known orphan: Accessory implicated in a new twist. Neuron. 17:1996;571-574.
72. Lucidi-Phillipi C. A., Clary D. O., Reichardt L. F., Gage F. H. TrkA activation is sufficient to rescue axotomized cholinergic neurons. Neuron. 16:1996;653-663.
73. Maroney A. C., Glicksman M. C., Basma A. N., Walton K. M., Knight E. Jr., Murphy C. A., Bartlett B. A., Finn J. P., Angeles T., Matsuda Y., Neff N. T., Dionne C. A. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18:1998;104-111.
74. Marte B. M., Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22:1997;355-358.
75. Maysinger D., Piccardo P., Liberini P., Jalsenjak I., Cuello C. Encapsulated genetically engineered fibroblasts: Release of nerve growth factor and effects in vivo on recovery of cholinergic markers after devascularizing cortical lesions. Neurochem. Int. 24:1994;495-503.
76. Meakin S. O., Shooter E. M. The nerve growth factor family of receptors. Trends Neurosci. 15:1992;323-331.
77. Miao N., Wang M., Ott J. A., D'Alessandro J. S., Woolf T. M., Bumcrot D. A., Mahanthappa K., Pang K. Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insultin vitro. J. Neurosci. 17:1997;5891-5899.
78. Miller R. G., Bryan W. W., Dietz M. A., Munsat T. L., Petajan J. H., Smith S. A., Goodpasture J. C. Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis. Neurology. 47:1996a;1329-1331.
79. Miller R. G., Petajan J. H., Bryan W. W., Armon C., Barohn R. J., Goodpasture J. C., Hoagland R. J., Parry G. J., Ross M. A., Stromatt S. C. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann. Neurol. 39:1996b;256-260.
80. Moriguchi T., Kawasaki H., Matsuda S., Gotoh Y., Nishida E. Evidence for multiple activators for stress-activated protein kinases/c-Jun amino-terminal kinases. J. Biol. Chem. 270:1995;12969-12972.
81. Negro A., Tavella A., Grandi C., Skaper S. D. Production and characterization of recombinant rat brain-derived neurotrophic factor and neurotrophin-3 from insect cells. J. Neurochem. 62:1994;471-478.
82. ras. J. Biol. Chem. 268:1993;25329-25333.
83. ras. Eur. J. Neurosci. 7:1995;344-350.
84. Oppenheim R. W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;451-501.
85. Oshima M., Sithanandam G., Rapp U., Guroff G. The phosphorylation and activation of B-raf in PC12 cells stimulated by nerve growth factor. J. Biol. Chem. 266:1993;23753-23760.
86. Peng X., Greene L., Kaplan D., Stephens R. Deletion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis. Neuron. 15:1995;395-406.
87. Penn R. D., Kroin J. S., York M. M., Cederbaum J. M. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery. 40:1997;94-99.
88. Philpott K. L., McCarthy M. J., Klippel A., Rubin L. L. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J. Cell Biol. 139:1997;809-815.
89. Pratt B. M., McPherson J. M. TGF-beta in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev. 8:1997;267-292.
90. Pshenichkin S. P., Wise B. C. Okadaic acid increases nerve growth factor secretion, mRNA stability, and gene transcription in primary cultures of cortical astrocytes. J. Biol. Chem. 270:1995;5994-5999.
91. Purves D. Body and Brain. A Trophic Theory of Neural Connections. 1988;Harvard Univ. Press, Cambridge.
92. Rabin S., Cleghorn V., Kaplan D. SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol. Cell. Biol. 13:1993;2203-2213.
93. Schaap D., van der Wal J., Howe L. R., Marshall C. J., van Blitterswijk W. J. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J. Biol. Chem. 268:1993;20232-20236.
94. Schlessinger J. SH2/SH3 signaling proteins. Curr. Opin. Gent. Dev. 4:1994;25-30.
95. Schubert D., Kimura H., LaCorbiere M., Vaughan J., Karr D., Fischer W. H. Activin is a nerve cell survival molecule. Nature. 344:1990;868-870.
96. Segal R. A., Greenberg M. E. Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19:1996;463-489.
97. Seiger A., Nordberg A., von Holst H., Backman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: The first attempt of a possible future treatment strategy. Behav. Brain Res. 57:1993;255-261.
98. +. Dev. Brain Res. 101:1997;197-206.
99. Skaper S. D., Floreani M., Negro A., Facci L., Giusti P. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: Selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J. Neurochem. 70:1998;1859-1868.
100. Snider W. D. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell. 77:1994;627-638.
101. Stahl N., Yancopoulos G. D. The alphas, betas, and kinases of cytokine receptor complexes. Cell. 74:1993;587-590.
102. Stahl N., Yancopoulos G. D. The tripartite CNTF receptor complex: Activation and signaling involves components shared with other cytokines. J. Neurobiol. 25:1994;1454-1466.
103. Steiner J. P., Connolly M. A., Valentine H. L., Hamilton G. S., Dawson T. M., Hester L., Snyder S. H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nature. Med. 3:1997a;421-428.
104. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M., Cohen N., Snyder S. H. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 358:1992;584-587.
105. Steiner J. P., Hamilton G. S., Ross D. T., Valentine H. L., Guo H., Connolly M. A., Liang S., Ramsey C., Li J.-H. J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A. C., Suzdak P. D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA. 94:1997b;2019-2024.
106. Szeberenyi J., Cai H., Cooper G. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10:1990;5324-5332.
107. Tessier-Lavigne M., Goodman C. S. The molecular biology of axon guidance. Science. 274:1996;1123-1133.
108. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
109. Thoenen H., Barde Y.-A. Physiology of nerve growth factor. Physiol. Rev. 60:1980;1284-1335.
110. Thome J., Foley P., Riederer P. Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article. J. Neural Transm. 105:1998;85-100.
111. Tian S.-S., Lamb P., King A. G., Miller S. G., Kessler L., Leungo J. I., Averill L., Johnson R. K., Gleason J. G., Pelus L. M., Dillon S. B., Rosen J. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science. 281:1998;257-259.
112. Tolkovsky A. Neurotrophic factors in action - New dogs and new tricks. Trends Neurosci. 20:1997;1-3.
113. Tournier C., Whitmarsh A. J., Cavanagh J., Barrett T., Davis R. J. Mitogen-activated kinase kinase 7 is an activator of the c-Jun amino terminal kinase. Proc. Natl. Acad. Sci. USA. 94:1997;7337-7342.
114. Virdee K., Tolkovsky A. M. Activation of p44 and p42 MAP kinases is not essential for the survival of rat sympathetic neurons. Eur. J. Neurosci. 7:1995;2159-2169.
115. Virdee K., Tolkovsky A. M. Inhibition of p42 and p44 mitogen-activated protein kinase activity by PD98059 does not suppress nerve growth factor-induced survival of sympathetic neurones. J. Neurochem. 67:1996;1801-1805.
116. Virdee K., Bannister A. J., Hunt S. P., Tolkovsky A. M. Comparison between the timing of JNK activation, c-Jun phosphorylation, and onset of death commitment in sympathetic neurons. J. Neurochem. 69:1997;550-561.
117. Vogel K. S., Brannan C. I., Jenkins N. A., Copeland N. G., Parada L. F. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell. 82:1995;733-742.
118. Walicke P. A. Novel neurotrophic factors, receptors, and oncogenes. Annu. Rev. Neurosci. 12:1989;103-126.
119. Walsh F. S., Doherty P. Neural cell adhesion molecules of the immunoglobulin superfamily: Role in axon growth and guidance. Annu. Rev. Cell. Dev. Biol. 13:1997;425-456.
120. Weiss A., Schlessinger J. Switching signals on or off by receptor dimerization. Cell. 94:1998;277-280.
121. Williams L. R., Inouye G., Cummins V., Pelleymounter M. A. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J. Pharmacol. Exp. Ther. 277:1997;1140-1151.
122. Wood K. W., Qi H., D'Arcangelo G., Armstrong R. C., Roberts T. M., Halegoua S. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: A potential role for cellular rat kinases in neuronal growth factor signal transduction. Proc. Natl. Acad. Sci. USA. 90:1993;5016-5020.
123. Wood K. W., Sarnecki C., Roberts T. M., Blenis J. Ras mediates nerve growth factor receptor modulation of three signal-transduction protein kinases: MAP kinase, Raf-1, and RSK. Cell. 68:1992;1041-1050.
124. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
125. Yamada K., Nitta A., Hasegawa T., Fuji K., Hiramatsu M., Kameyama T., Furukawa Y., Hayashi K., Nabeshima T. Orally active NGF synthesis stimulators: Potential therapeutic agents in Alzheimer's disease. Behav. Brain Res. 83:1997;117-122.
126. Yao R., Cooper G. M. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.
127. Yuen E. C., Mobley W. C. Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40:1996;346-354.